CTOs on the Move


 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

Radeas

Radeas is a clinical laboratory that offers testing for toxicology, COVID-19, PGX, UTI, and blood. They provide timely and accurate information to help guide decisions and ensure improved outcomes, with excellent customer service and a broad network of...

Adam's County Regional Medical Center

Adam's County Regional Medical Center is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Seaman, OH. To find more information about Adam's County Regional Medical Center, please visit www.acrmc.com

Clinex Retina Resource

Clinex Retina Resource, LLC is a Augusta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Premise Corporation

Premise Corporation is a Farmington, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Saint Jude Medical

St. Jude Medical is a global medical device manufacturer dedicated to transforming the treatment of some of the world’s most expensive epidemic diseases. We do this by developing cost-effective medical technologies that save and improve lives. St. Jude Medical provides safe and effective technologies that are of the highest quality—and that quality is something we take very seriously because we know patients around the world rely on our technologies. Our approximately 18,000 employees are passionate in their commitment to this priority. Headquartered in St. Paul, Minn., St. Jude Medical has four major clinical focus areas: cardiac rhythm management, atrial fibrillation, cardiovascular and neuromodulation. The St. Jude Medical product portfolio includes implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices, pacemakers, remote monitoring systems, cardiac mapping and visualization systems, catheter-based ablation devices, vascular closure devices, structural heart products, spinal cord stimulation, peripheral nerve stimulation and deep brain stimulation devices. All qualified applicants will receive consideration for employment without regard to race, color, creed, religion, sex, national origin, marital status, age, citizenship, protected veteran status, sexual orientation, gender identity and/or gender expression, status with respect to public assistance, or disability status.